These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8186655)

  • 1. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
    Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Moore RD; Keruly J; Richman DD; Creagh-Kirk T; Chaisson RE
    AIDS; 1992 Jul; 6(7):671-7. PubMed ID: 1503686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of CD4 cell decline and prediction of survival in zidovudine-treated patients.
    Easterbrook PJ; Emami J; Gazzard B
    AIDS; 1993 Oct; 7(10):959-67. PubMed ID: 7903542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
    Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
    Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of antiviral therapy with zidovudine: a retrospective study on HIV-positive hemophiliacs in Italy. Italian Group of Congenital Coagulopathies.
    Arcieri R; Puopolo M; Baudo F; Chiarotti F; De Rosa V; Schinaia N; Mori PG; Ghirardini A
    Haematologica; 1995; 80(1):25-30. PubMed ID: 7758987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Impact of zidovudine treatment and the pneumocystis carinii prophylaxis in natural history of patients with HIV infection].
    Sáiz Hervas E; Castilla Castellano V; Miquel Plaza J; Benito Blanco AM; Martín Llorens MM; Pastor de Blas M; Izquierdo P; Muñoz Jareño MA; Sierra A; Nieto MA; Moreno Collado AM; Fraguas C
    An Med Interna; 1998 Mar; 15(3):132-7. PubMed ID: 9580410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival without clinical AIDS after CD4+ cell counts fall below 200 x 10(6)/l.
    Hoover DR; Rinaldo C; He Y; Phair J; Fahey J; Graham NM
    AIDS; 1995 Feb; 9(2):145-52. PubMed ID: 7718184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Logarithmic relationship of the CD4 count to survival in patients with human immunodeficiency virus infection.
    Nightingale SD; Jockusch JD; Haslund I; Cal SX; Peterson DM; Loss SD
    Arch Intern Med; 1993 Jun; 153(11):1313-8. PubMed ID: 8099477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk of the development of dementia after interruption of zidovudine treatment].
    Teira R; Uriarte E; Muñoz J; Uterga JM; Sádaba F; Zubero Z; Santamaría JM
    Med Clin (Barc); 1998 Sep; 111(9):325-8. PubMed ID: 9810533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in survival over time after a first episode of Pneumocystis carinii pneumonia for European patients with acquired immunodeficiency syndrome. Multicentre Study Group on AIDS in Europe.
    Lundgren JD; Barton SE; Katlama C; Ledergerber B; González-Lahoz J; Pinching AJ; Proenca R; Hemmer R; Pedersen C; Phillips AN
    Arch Intern Med; 1995 Apr; 155(8):822-8. PubMed ID: 7717790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing incidence of HIV-induced brain lesions in Oslo, 1983-1994: effects of zidovudine treatment.
    Maehlen J; Dunlop O; Liestøl K; Dobloug JH; Goplen AK; Torvik A
    AIDS; 1995 Oct; 9(10):1165-9. PubMed ID: 8519453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Withdrawal of Pneumocystis carinii pneumonia prophylaxis in patients receiving efficacious combined antiretroviral treatment. Study of 85 cases].
    García Vázquez E; de Górgolas Hernández M; García Delgado R; Fernández Guerrero ML
    Med Clin (Barc); 1999 Jun; 113(3):89-90. PubMed ID: 10464742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
    Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
    Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 lymphocyte count as an indicator of delay in seeking human immunodeficiency virus-related treatment.
    Katz MH; Bindman AB; Keane D; Chan AK
    Arch Intern Med; 1992 Jul; 152(7):1501-4. PubMed ID: 1352676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of the survival benefit of zidovudine therapy in HIV infection.
    Moore RD; Keruly JC; Chaisson RE
    Arch Intern Med; 1996 May; 156(10):1073-7. PubMed ID: 8638994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
    Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
    Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival among HIV-infected patients after initiation of triple-drug antiretroviral regimens.
    Hogg RS; Yip B; Kully C; Craib KJ; O'Shaughnessy MV; Schechter MT; Montaner JS
    CMAJ; 1999 Mar; 160(5):659-65. PubMed ID: 10102000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.
    Mussini C; Pezzotti P; Govoni A; Borghi V; Antinori A; d'Arminio Monforte A; De Luca A; Mongiardo N; Cerri MC; Chiodo F; Concia E; Bonazzi L; Moroni M; Ortona L; Esposito R; Cossarizza A; De Rienzo B
    J Infect Dis; 2000 May; 181(5):1635-42. PubMed ID: 10823763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Survival of patients with zidovudine resistant HIV].
    Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
    Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.